SCHEMBL6983142

SCHEMBL6983142

CC(C)CNNC(=O)[C@H](CC(C)C)[C@H](CCNC(=O)c1ccccc1)C(=O)OC(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
EPHX2 P34913 1/20 0.40
CTSK P43235 2/20 0.38
KCNA5 P22460 2/20 0.38
KDM4E B2RXH2 1/20 0.38
PKM P14618 1/20 0.38
ADAM17 P78536 1/20 0.37
ESRRG P62508 1/20 0.37
CTSL P07711 2/20 0.36
CTSB P07858 1/20 0.36
CTSS P25774 1/20 0.36
MMP1 P03956 1/20 0.36
MMP2 P08253 1/20 0.36
MMP3 P08254 1/20 0.36
MMP9 P14780 1/20 0.36
MMP13 P45452 1/20 0.36
MMP14 P50281 1/20 0.36
NR1H2 P55055 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6980588 0.86 NPC1 (0.48) NPC1RAB9ASMN1; SMN2EPHX2KCNA5
SCHEMBL6980590 0.86 NPC1 (0.48) NPC1RAB9ASMN1; SMN2EPHX2KCNA5
SCHEMBL6986672 0.82 MMP1 (0.44) CTSKCTSSMMP1MMP3MMP9
SCHEMBL7955112 0.78 MAPT (0.40) NPC1RAB9ASMN1; SMN2CTSKKDM4E
SCHEMBL7836648 0.78 MAPT (0.40) NPC1RAB9ASMN1; SMN2CTSKKDM4E
SCHEMBL7955175 0.77 KMT2A (0.43) NPC1RAB9ASMN1; SMN2CTSKKDM4E
SCHEMBL6981775 0.77 KMT2A (0.43) NPC1RAB9ASMN1; SMN2CTSKKDM4E
SCHEMBL27508603 0.77 KMT2A (0.43) NPC1RAB9ASMN1; SMN2CTSKKDM4E
SCHEMBL7957323 0.77 CTSK (0.53) CTSKCTSLCTSBCTSS
SCHEMBL6942460 0.77 ADAM17 (0.46) CTSKADAM17MMP1MMP2MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1089964-B1 HYDRAZINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2003-10-29 EP disclosed
US-6239151-B1 TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES, OSTEOARTHRITIS, RESPIRATORY DISEASES, TUMORS, CACHEXIA, CARDIOVASCULAR DISEASES, FEVER, HAEMORRHAGE AND SEPSIS, HYDRAZINE DERIVATIVES, HOFFMANN-LA ROCHE INC. 2001-05-29 US disclosed